The complexities of TGF-β action during mammary and squamous cell carcinogenesis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Pharmaceutical Biotechnology

• Publication date

  2011-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138920111798808284PMID 21619543PMCID PMC3520605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma

  2014cited by this paper
• Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy

  2010cited by this paper
• Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis.

  2010cited by this paper
• Smad signaling is required to maintain epigenetic silencing during breast cancer progression.

  2010cited by this paper
• From the cradle to the grave: activities of GATA‐3 throughout T‐cell development and differentiation

  2010cited by this paper
• Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth

  2010cited by this paper
• Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

  2010cited by this paper
• Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis

  2010cited by this paper
• Epithelial‐Mesenchymal Transition‐Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells

  2010cited by this paper
• Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing

  2010cited by this paper
• The polarization of immune cells in the tumour environment by TGFβ

  2010cited by this paper
• Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

  2009cited by this paper
• Smad3 Differentially Regulates the Induction of Regulatory and Inflammatory T Cell Differentiation*

  2009cited by this paper
• Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients

  2009cited by this paper
• FOXP3 expression and overall survival in breast cancer.

  2009cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009cited by this paper
• The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer

  2009cited by this paper
• Transforming growth factor-β in breast cancer: too much, too late

  2009cited by this paper
• Roles of TGFβ in metastasis

  2009cited by this paper
• Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.

  2009cited by this paper
• Revisiting the seed and soil in cancer metastasis.

  2009cited by this paper
• Gain or loss of TGF-β signaling in mammary carcinoma cells can promote metastasis

  2009cited by this paper
• The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.

  2009cited by this paper
• Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

  2009cited by this paper
• Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells

  2009cited by this paper
• The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner

  2008cited by this paper
• alpha3beta1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice.

  2008cited by this paper
• TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.

  2008cited by this paper
• Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas

  2008cited by this paper
• Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression.

  2008cited by this paper
• Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.

  2008cited by this paper
• An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.

  2008cited by this paper
• Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds.

  2008cited by this paper
• Cripto-1 Alters Keratinocyte Differentiation via Blockade of Transforming Growth Factor-β1 Signaling: Role in Skin Carcinogenesis

  2008cited by this paper
• Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.

  2008cited by this paper
• Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development

  2007cited by this paper
• Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.

  2007cited by this paper
• Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.

  2006cited by this paper
• C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.

  2006cited by this paper
• Transgenic Mice Overexpressing a Dominant-negative Mutant Type II Transforming Growth Factor ßReceptor Show Enhanced Tumorigenesis in the Mammary Gland and Lung in Response to the Carcinogen

  2006cited by this paper
• Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility.

  2006cited by this paper
• A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.

  2006cited by this paper
• Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress.

  2006cited by this paper
• Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

  2006cited by this paper
• SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis.

  2006cited by this paper
• Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies.

  2005cited by this paper
• Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.

  2005cited by this paper
• Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.

  2005cited by this paper
• Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-β1 expression

  2005cited by this paper
• Faculty Opinions recommendation of Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity.

  2005cited by this paper
• Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.

  2005cited by this paper
• Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

  2005cited by this paper
• Two somatic biallelic lesions within and near SMAD4 in a human breast cancer cell line

  2005cited by this paper
• Breast Cancer Metastasis to Bone: Mechanisms of Osteolysis and Implications for Therapy

  2005cited by this paper
• Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.

  2005cited by this paper
• Genetic Polymorphisms of the Transforming Growth Factor-β1 Gene and Breast Cancer Risk: A Possible Dual Role at Different Cancer Stages

  2005cited by this paper
• Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity

  2005cited by this paper
• Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow.

  2004cited by this paper
• Smad-Binding Defective Mutant of Transforming Growth Factor β Type I Receptor Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines

  2004cited by this paper
• Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis

  2004cited by this paper
• Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis.

  2004cited by this paper
• Overexpression of Transforming Growth Factor β1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation

  2004cited by this paper
• Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.

  2004cited by this paper
• Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer Cells

  2004cited by this paper
• The TGF-beta1 antisense oligonucleotide AP 11014 for the treatment of non-small cell lung, colorectal and prostate cancer: Preclinical studies.

  2004cited by this paper
• Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

  2003cited by this paper
• A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.

  2003cited by this paper
• Mobilization and homing of bone marrow stromal cells in myocardial infarction.

  2003cited by this paper
• Integration of Smad and MAPK pathways: a link and a linker revisited.

  2003cited by this paper
• Role of the stromal microenvironment in carcinogenesis of the prostate

  2003cited by this paper
• Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.

  2003cited by this paper
• Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003cited by this paper
• Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.

  2003cited by this paper
• Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human

  2003cited by this paper
• Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

  2003cited by this paper
• The two faces of transforming growth factor beta in carcinogenesis.

  2003cited by this paper
• Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.

  2003cited by this paper
• The Integrin {alpha}v{beta}3 and CD44 Regulate the Actions of Osteopontin on Osteoclast Motility

  2003cited by this paper
• Transforming growth factor-beta in T-cell biology.

  2002cited by this paper
• E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression.

  2002cited by this paper
• The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies

  2002cited by this paper
• Consequences of altered TGF-β expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects

  2002cited by this paper
• Immune-Mediated Eradication of Tumors through the Blockade of Transforming Growth Factor-beta Signaling in T Cells

  2002cited by this paper
• An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal.

  2002cited by this paper
• Transforming growth factor-beta1 mediates cellular response to DNA damage in situ.

  2002cited by this paper
• Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

  2002cited by this paper
• Role of stroma in carcinogenesis of the prostate.

  2002cited by this paper
• Metastasis is driven by sequential elevation of H-ras and Smad2 levels

  2002cited by this paper
• Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.

  2001cited by this paper
• TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

  2001cited by this paper
• Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.

  2001cited by this paper

• Influence of Tyrosine Kinase Inhibitors and Everolimus on TGFβ1 and TGF-β Receptor 2 in Squamous Cell Carcinoma Cells

  2024cites this paper
• Exogenous Transforming Growth Factor-β in Brain-Induced Symptoms of Central Fatigue and Suppressed Dopamine Production in Mice

  2021cites this paper
• Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses.

  2018cites this paper
• CD109 and squamous cell carcinoma

  2018cites this paper
• Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy

  2017cites this paper
• CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma

  2017cites this paper
• TGF&bgr; pathway inhibition in the treatment of non‐small cell lung cancer

  2017cites this paper
• Inactivation of TGFb receptors in stem cells drives cutaneous squamous cell carcinoma

  2016cites this paper
• Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma.

  2016cites this paper
• Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma

  2016cites this paper
• Cadherins: The Superfamily Critically Involved in Breast Cancer.

  2016cites this paper
• Monoclonal antibodies as powerful tools in diagnosis and therapy

  2015influential citation
• Optimisation d'un vaccin thérapeutique dans les tumeurs des voies aérodigestives supérieures associées aux papillomavirus : rôle de l'induction d'une immunité muqueuse et de la combinaison à la radiothérapie

  2015cites this paper
• [Tumor microenvironment: regulatory cells and immunosuppressive cytokines].

  2014cites this paper
• EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis

  2014cites this paper
• The role played by the microenvironment in site-specific metastasis.

  2014cites this paper
• Endothelium-dependent epithelial-mesenchymal transition of tumor cells: exclusive roles of transforming growth factor β1 and β2.

  2013cites this paper
• CLIC4 is a tumor suppressor for cutaneous squamous cell cancer.

  2012cites this paper
• Complexities of TGF-β Targeted Cancer Therapy

  2012cites this paper
• P,p' DDE regulated gene expression and possible mechanisms of action in breast tumor formation

  2011cites this paper
• Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.

  2011cites this paper